CStone Pharmaceuticals — Board/Management Information 2019

May 15, 2019

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2616)

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

The members of the board of directors (the “ Board ”) of CStone Pharmaceuticals (the “ Company ”) are set out below.

Executive director

Dr. Frank Ningjun Jiang (Chairman and Chief Executive Officer)

Non-executive director

Dr. Wei Li

Mr. Qun Zhao

Mr. Yanling Cao

Mr. Guobin Zhang

Dr. Lian Yong Chen

Independent non-executive directors

Dr. Paul Herbert Chew

• Mr. Ting Yuk Anthony Wu Mr. Hongbin Sun

The Board has four Board committees. The table below provides the membership information of these committees on which each director of the Company serves.

	Audit Committee	Compensation Committee	Nomination Committee	Strategy Committee
Dr. Frank Ningjun Jiang			C	C
Dr. Wei Li		M
Mr.Qun Zhao
Mr. YanlingCao			M
Mr. Guobin Zhang
Dr. Lian YongChen				M
Dr. Paul Herbert Chew	M	M	M	M
Mr. TingYuk AnthonyWu	M	C	M
Mr. Hongbin Sun	C		M

Notes:

• C Chairman of the relevant Board committee

• M Member of the relevant Board committee

May 15, 2019